💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Myriad Genetics, Inc. (MYGN)
« Back to company indexMYGN Chatter Timeline
Stock Ticker for MYGN
Most Active Tweeters for MYGN
| User | Tweets |
|---|---|
| @FlashAlert_me | 7 |
| @Tickeron | 5 |
| @otcdynamics | 5 |
| @sbwcws | 4 |
| @StockNewsBot2 | 4 |
Recent Tweets for MYGN
 |
@ShortAlgoTrades $MYGN Waiting for Short signal on MYGN with https://t.co/sjROqPnc9P. Learn more at https://t.co/ZzhEUJ8ooJ https://t.co/NpyejFJT1P August 4th 2021, 10:08pm |
 |
@ShogunTrade $MYGN Waiting for Short signal on MYGN with https://t.co/5jHMqdsWui https://t.co/oPrKCEkyVr August 4th 2021, 10:08pm |
 |
@investor_feed $MYGN 10-Q Myriad Genetics (4 Aug, 4:06pm) ? 2021 Q2 Earnings https://t.co/xQHcY5T1Hz #MYGN #10Q #MyriadGenetics #Earnings August 4th 2021, 8:08pm |
 |
@FlashAlert_me $MYGN [15s. delayed] filed form 10-Q on August 04, 16:06:34 https://t.co/D3KyU9zWua August 4th 2021, 8:08pm |
 |
@ringoftrades7 $MYGN Waiting for Short signal on MYGN https://t.co/CnYjEpKUlI August 4th 2021, 5:08pm |
 |
@Tickeron $MYGN in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators:… https://t.co/ZQ2Z8fkS7U August 4th 2021, 12:08pm |
 |
@SwingTradeBot $MYGN technical alerts: New 52 Week High, Expansion Breakout, Pocket Pivot, Wide Range Bar, MACD ... https://t.co/1ayvR7H0Cj August 4th 2021, 12:08pm |
 |
@kwhenfinance Myriad Genetics, Inc. Shares Climb 3.6% Past Previous 52-Week High - Market Mover https://t.co/53pwJgwNEW $MYGN #stockmarket #kwhenfinance August 4th 2021, 11:08am |
|
@kwhenfinance Myriad Genetics, Inc. Shares Close the Day 14.2% Higher - Daily Wrap https://t.co/ucJP61003X $MYGN #stockmarket #kwhenfinance August 4th 2021, 11:08am |
|
@ShortAlgoTrades $MYGN Awaiting Short Signal. Chart by UltraAlgo! https://t.co/pcSzyX5bGB August 4th 2021, 10:08am |
 |
@otcdynamics $MYGN Theragnostics Strengthens Board of Directors with Key Appointments https://t.co/ZAVLI89i5z August 4th 2021, 7:08am |
|
@FlashAlert_me $MYGN [15s. delayed]: Issued Press Release on August 04, 03:00:00: Theragnostics Strengthens Board of Directors wit… https://t.co/VgRvfpGkqc August 4th 2021, 7:08am |
 |
@quantisnow $MYGN $BTX ? Theragnostics Strengthens Board of Directors with Key Appointments https://t.co/63V0W3qsfw 30s delayed. August 4th 2021, 7:08am |
 |
@newsfilterio Theragnostics Strengthens Board of Directors with Key Appointments $BTX $MYGN https://t.co/wB1rKXFod8 August 4th 2021, 7:08am |
 |
@ABetterInnovat1 RT @MarketWN: NEWS: $MYGN Myriad Genetics, inc (MYGN) Q2 2021 Earnings Call Transcript https://t.co/ghRINrB15v #MWN #Stocks @usstockb… August 4th 2021, 3:08am |
 |
@MarketWN NEWS: $MYGN Myriad Genetics, inc (MYGN) Q2 2021 Earnings Call Transcript https://t.co/ghRINrB15v #MWN #Stocks… https://t.co/jLj14oUde8 August 4th 2021, 2:08am |
 |
@EarningsAlley Myriad Genetics, Inc. $MYGN held an earnings call on 8/3/2021. Here are the highlights: August 4th 2021, 2:08am |
 |
@SiteFocusHQ $MYGN Earnings Intelligence Analysis of recent earnings identified Myriad Genetics business focus on (business,cap… https://t.co/Ovz15axaIC August 4th 2021, 12:08am |
 |
@SeekingAlpha $MYGN - Myriad Genetics' (MYGN) CEO Paul Diaz on Q2 2021 Results - Earnings Call Transcript.… https://t.co/mpLI8z9fOm August 4th 2021, 12:08am |
|
@MarketWN Just In: $MYGN Shares of Myriad Genetics Inc. (MYGN) Rise Above Previous 52-Week High https://t.co/xywOJqpAcN… https://t.co/DXcFLNJWAd August 3rd 2021, 11:08pm |
|
@MarketWN BREAKING NEWS: $MYGN Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to… https://t.co/T6ZdXkFrnE August 3rd 2021, 11:08pm |
|
@ShogunTrade $MYGN Waiting for Short signal on MYGN with https://t.co/RbmGb6eXLz https://t.co/4IKlfJkT84 August 3rd 2021, 10:08pm |
 |
@alphacharts365 $MYGN had earnings today so I never took this trade https://t.co/2sSLgNyODr https://t.co/o4i4IMzwUr August 3rd 2021, 8:08pm |
 |
@tradingtimes4 $MYGN DAILY. NO OPINION GIVEN. ARE WE GOING TO BE BREAKIKNG OUT HERE? https://t.co/kIBDwefwma August 3rd 2021, 8:08pm |
 |
@NewsQuantified $MYGN today announced financial results for its second quarter ended June 30, 2021 and provided an update on recent… https://t.co/cdYVOLblnf August 3rd 2021, 7:08pm |
 |
@MarketChmln $MYGN share price increases 13.0%. MYGN stock price today hit a new 52 week high. See recent news release. https://t.co/SESIEyDigB August 3rd 2021, 7:08pm |
|
@ringoftrades7 $MYGN Waiting for Short signal on MYGN https://t.co/61MLSXxvgk August 3rd 2021, 7:08pm |
 |
@akramsrazor This $mygn vs $nvta long term shareholder battle just gets worse by the day. August 3rd 2021, 6:08pm |
 |
@42Stocks https://t.co/dtAK7h3mik 2021-AUG-03 1:30pm $MYGN #MyriadGenetics up 12.52% = $305.1 million gain. (Aug 03) Myriad… https://t.co/CxpxgpPWSP August 3rd 2021, 5:08pm |
 |
@StockPods $MYGN Earnings Call Today: 4:30 PM EST Webcast: https://t.co/otfvqhsdTU Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 August 3rd 2021, 4:08pm |
 |
@A1Syad $MYGN Looks overbought Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw #StockMarket #stocks… https://t.co/6nsV37E6ql August 3rd 2021, 4:08pm |
 |
@SmallCapsDaily $MYGN Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Str… https://t.co/UWe65IamdL August 3rd 2021, 4:08pm |
 |
@MinteractApp $MYGN company #profile, #Fundamental and #Technical Analysis Score Update (FA Score, TA Score) #stocks #stock… https://t.co/ACfBKNxXnj August 3rd 2021, 3:08pm |
 |
@stockwatcherapp $MYGN is up 10.64% to $34.15 August 3rd 2021, 2:08pm |
 |
@AlertTrade SOCIAL ACTIVITY: $MYGN - Myriad Genetics, Inc https://t.co/vaE4NdBZBV ? TradeIdeas via ? https://t.co/VS8RO1bzXJ August 3rd 2021, 2:08pm |
|
@AlertTrade UP WITH EARNINGS: $MYGN Myriad Genetics, Inc https://t.co/sl5z2wlBaC ? TradeIdeas via ? https://t.co/VS8RO1bzXJ August 3rd 2021, 2:08pm |
 |
@Briefingcom $MYGN: Myriad Genetics beats by $0.23, beats on revs https://t.co/XiD2rCjhwZ August 3rd 2021, 1:08pm |
 |
@mehabecapital (Earnings) Myriad Genetics ( $MYGN ) Actual.EPS=0.12 vs Est.EPS=-0.0944, Actual.Rev=189.4M vs Est.Rev=162.54M, Last… https://t.co/3wnaOiypUe August 3rd 2021, 11:08am |
 |
@ethanFlare $MYGN - Myriad Genetics EPS beats by $0.22, beats on revenue Cap size: mid, Float 97.7%, Short Interest 8.4%, Insti… https://t.co/ayTYIzkmXM August 3rd 2021, 11:08am |
|
@otcdynamics $MYGN Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Str… https://t.co/AaZXlccfNV August 3rd 2021, 11:08am |
 |
@bonjour247 RT @sbwcws: Myriad Genetics not providing Q3, 2021 financial guidance $MYGN August 3rd 2021, 11:08am |
 |
@EdgarInsider New Form 8-K [Press/News Current Report] entry filed by $MYGN MYRIAD GENETICS INC https://t.co/Tjk4iMdR7N August 3rd 2021, 11:08am |
 |
@sbwcws Myriad Genetics provides business transformation updates $MYGN August 3rd 2021, 11:08am |
|
@sbwcws Myriad Genetics not providing Q3, 2021 financial guidance $MYGN August 3rd 2021, 11:08am |
 |
@StckPro $MYGN NEW ARTICLE : Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to… https://t.co/mYex9PUxII August 3rd 2021, 11:08am |
|
@sbwcws Myriad Genetics reports Q2 adjusted EPS 12c, consensus (9c) $MYGN August 3rd 2021, 11:08am |
|
@FlashAlert_me $MYGN [15s. delayed]: Issued Press Release on August 03, 07:05:00: Myriad Genetics Delivers Strong Revenue and Earn… https://t.co/xN1kJPTMrE August 3rd 2021, 11:08am |
 |
@StockNewsBot2 $MYGN Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Str… https://t.co/l0dhzCTEgs August 3rd 2021, 11:08am |
|
@investor_feed $MYGN 8-K Myriad Genetics (3 Aug, 7:05am) ? Myriad Genetics Delivers Strong Revenue and Earnings Growth in Jun… https://t.co/7XDCkQo6Fj August 3rd 2021, 11:08am |
|
@FlashAlert_me $MYGN [15s. delayed] filed form 8-K on August 03, 07:05:25 https://t.co/JZESpKZ9F7 August 3rd 2021, 11:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?